Reddit Posts
Do y’all think the Autonomix (NASDAQ: AMIX) IPO tomorrow has the potential to be the TOP IPO of 2024?
EBYH - "We are thrilled to conclude 2023 with our most substantial orders to date".
If an acquisition is announced at $X/share, why would anyone sell it for LESS?!
Individual stocks vs ETF vs REIT vs Robo-investing
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
Is having a money manager/"Private CFO" worth it?
What would you buy for a short-term medium risk profit expectation right now? Would you sell your most disappointing stock to buy that?
How do I decide between initating a new position vs adding to an existing one?
Looking for help on when to initiate a new position vs DCA an existing one?
Time to dump tech and buy dividend stocks?
Pharmaceuticals break COVID lows trend line signaling end to Bear Market
AbbVie down 7%. Humira sales down 25% As Biosimilars Hammer Away At Sales
AbbVie gains as Skyrizi succeeds in ulcerative colitis (NYSE:ABBV)
2023-02-27 Wrinkle-brain Plays (Mathematically derived options plays)
AbbVie sued in Netherlands for breaching human rights over Humira pricing (NYSE:ABBV)
Next big wave of patent cliffs ahead; expect biopharma M&A to rise (NYSE:ABBV)
$BIOR rising on short squeeze lists. Currently only $30M market cap... Imagine would it could be worth to ABBV as a way to regain patent protection on Humira... explains current $65 price target. Could run incredibly high...
The investor who bought 2.1 Million shares the last session is $7,035,000.00 wealthier in just 24 hours
My short, intermediate, &long and good divident stock reversal confirmed. Shortsqueeze and gamma squeeze (score 87) is a real possibility
AbbVie sets outlook below consensus amid generic threat to best selling drug (NYSE:ABBV)
AbbVie pins hopes on newer drugs and deals to face Humira knockoffs (NYSE:ABBV)
Drug price inflation continues upward momentum at 3.8% – report (NYSE:ABBV)
U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates (NYSE:ABBV)
AbbVie’s global bestseller Humira to face knockoffs this week (NYSE:ABBV)
My 2022 strategy been working well I guess ¯\_(ツ)_/¯
What are some good healthcare stocks to hold long-term?
Shorting ABBV: Machine Learning Model.
Looking for some constructive advice on my Roth portfolio. What would you cut to get this down to an even 10 stocks?
Why are people throwing money at TEVA after the recent Supreme Court ruling?
Birth control-related pharma plays $OGN $ABBV $TEVA $JNJ
Birth Control-related Pharma Plays $OGN $ABBV $TEVA $JNJ
What did you bought today? Just got some BMO and JPM pretty cheap myself!
$ABBV which trades at $140 has a stake in $XCUR which trades at 18 cents - they are partnered and its all confirmed in partners earnings call. I’ve been going through everything trying to figure out why this is so low and can’t rationalize it. Has .69 cash per share as well.
$XCUR - go through Ipsens Feb 2022 presentation - the partnership with $IPSEY is legit this was at $2 when it was announced. $ABBV must be legit as well:
$XCUR - go through Ipsens Feb 2022 presentation - the partnership with $IPSEY is legit this was at $2 when it was announced. $ABBV must be legit as well:
$XCUR it’s all fucking legit with $ABBV and $IPSEY cant believe it’s at .18 cents. It’s all confirmed on Ipsens earnings call four days ago.
Some big news on $XCUR in most recent $IPSEY Earnings Call they stated the partnerships are continuing. Which means $ABBV partnership still intact. This could be the $BNGO of this year running pennies to dollars.
If you only had to hold a few individual stocks, which would you choose? Or just throw everything in ETFs?
Fat bids on $XCUR all afternoon don’t think this is done. Maybe the partnership with $ABBV and $IPSEY are legit. They just have a shit CEO rn
Big picture on $XCUR is average cost is .80 and PTs range from .40-$6 I just think these prices won’t ever come back. Going long for better or worse but $ABBV partnership isn’t something that can be ignored the Chairman is the CEO of $HZNP
$XCUR - risky play but high risk high reward! The latest filing states the partnerships with ABBV and IPSEY are going fully ahead:
When Partnership news hits $XCUR it’s going straight to $1 at minimum. There’s no way these prices stay this low. When $ABBV announced it ran to $3.30 this could be the next $BNGO pennies to dollars imo
When Partnership news hits $XCUR it’s going straight to $1 at minimum. There’s no way these prices stay this low. When $ABBV announced it ran to $3.30
Partnership news is what will send $XCUR up im holding from .16 waiting til news hits. The partnerships with $ABBV and $IPSEY took it from .90-$3.30 we should have neuroscience partnership news soon worth $1.9B
Partnership news is what will send $XCUR up im holding from .16 waiting til news hits. The partnerships with $ABBV and $IPSEY took it from .90-$3.30 we should have neuroscience partnership news soon worth $1.9B
The major pharma partnerships with $ABBV and $IPSEY make $XCUR extremely undervalued. I can’t wrap head around it under $1 in all honesty. Sorry if keep posting and it’s turned spammy - go through all the DD and make mind up. In my mind it doesn’t make sense when partners were announced it was $3.50
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades $24) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades $24) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR - I think it can get to $15 on successful execution of partnerships they have locked contracts with $ABBV (trades $140 and $IPSEY trades. $15) worth 4 BILLION in revenue and are in the process of partnering Neuroscience and Pain side in early 2022. Institutions loaded at .33 off last offering:
$XCUR it’s partners trades at $140!!! $ABBV and $IPSEY. The CEO of $HZNP which trades at $90 is chairman of $XCUR - i think this is the next $BNGO and could potentially run to $10 - these partnerships aren’t a joke.
There’s a shit ton of naked shorts in $XCUR is nobody seeing this PA this could really go like $BNGO from pennies to $10+ these are some insane partnerships with major major pharma $ABBV trades at $140
$XCUR is a $PROG 2.0 - some warrants were issued at .01 but they haven’t redeemed the .27 warrants or the shares at .33 per Jan 2022 filing which would push the price to .50 minimum on execution. The neuroscience and pain partner will be announced in 2022 - it did a 60% move on IPSEN and $ABBV news:
$XCUR (currently 16 cents) - $ABBV and $IPSEY 1B Partnership Breakdown:
When $XCUR first IPO’d they issued it a $9 PT the fact it’s 16 cents now is unbelievable with an $ABBV and $IPSEY partnership. If you’re able to buy 100k shares rn and sit for a year or two it’s an easy 5-10X money imo.
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR - Partnered with $ABBV and $IPSEY - is this the next $BNGO type runner 🧐
$XCUR is very interesting down here partnered with $ABBV
How many of you use leverage or borrowed money to boost your portfolios?
Stocks you can’t wait to see dip because you’re itching to buy them
ABBV Valuation from $111 to $172...just like that huh?
ABBV Valuation from $111 to $172...just like that huh?
Buyout Coming Soon ABBV. Buy all you can, once in a Lifetime here
Earnings for this week & Next week (Me, ABBV, AMC, APPL, etc….)
Stock picks for a 10 year hold with the hope of 5x my money...which ones?
$ABBV short term calls Gain with more to come after Friday announcement with RGNX! Here we go!!!
Let's try $ABBV short term calls. Retina meeting this Friday. Data hopefully is good 10/8 high risk high reward calls. YOLO!
The Cutting Edge: $ATNF, $ABBV, and Adalimumab
Mentions
Love to see a green day and my ABBV holdings down 2.5% fuck this company
I'm down like 20-30% on JD rn, but I got leaps so im chillin for now. UNH and ABBV have fucked me, so I guess JD didn't have too
ABBV’s earnings showed mixed but good results + raised its guidance for next year - The stock plummeted 4% afterwards and I bought it at a discount thinking its a good stock and that the market judges too swiftly and it must go up again. What do you guys think ?
> They only keep going up The market for the past decade, other than the Covid dip, has gone up. > the price of companies don't necessarily go down all that much Yes, if the overall market is going up, you don't see the value of high dividend stocks going down all that much. However . . Other than ABBV, the other stocks you mentioned have badly underperformed the index. And most pharm companies, even established ones, are gambles.
Not entirely sure how the whole: "it goes down when the dividends are paid" works since I invest on ETFS right now, Dividend & Growth etfs, but the price of companies don't necessarily go down all that much or if they do it might be for a week or so. Just basing this on stocks like JNJ, PG, PEP and ABBV. They only keep going up and they pay $1/share per dividend payout and their stocks don't necessarily go down one dollar for long. I do have reservations investing on anything thats on the red during their 5 year to MAX tenure graphs. Though if I'm incorrect I'd appreciate a clarification since that could help with deciding better company stocks.
ABBV 255 calls. 0.05 price for potential 5x. I know nothing about the company it’s just the cheapest option within range. Figured I’d share for other degens
I’ve been with Amazon since the first split and WWE since 13.00. Those are my two favorites with Kodak and ABBV
I usually buy ABBV for recessions.
I have been investing in the stock market for about 30 years and as you can imagine, I have accumulated many shares of stocks. I have mainly bought and held Dividend Aristocrats. Some of my big stock positions include ABBV(3700 shares), MCD(2550 shares) MO(7400 shares). I have begun selling covered calls on the stocks that I own. If my stocks were to be assigned, I would be subjected to hefty capital gains taxes. So, I have written covered calls that are out of the money with about 2-4 weeks time to expiration., to lower my risk of getting assigned. The premiums are anemic but my goal is to earn about $1,000 every two weeks on my positions. Am I expecting too much? Is my strategy correct?
ABBV for botox, EOLS for their competitor
NVO, LLY, ABBV, JNJ, ... There's a lot of BP left.
Some of my highest conviction positions I haven't seen mentioned: SYK - for surgical robotics & med tech ABBV - drug portfolio & discovery AMAT - semiconductor tech TSM - the best semiconductor fab CRWV - complex AI infrastructure
I'm Bear-curious on ABBV.
MRK ABBV UNH BMY. Make Health Win Again.
ABBV put holder. Exiting tomorrow.. rough go.
I sold ABBV at 190 because 🥭 kept on threatening pharma tariffs 🤡
ABBV literally finishing all over my face wtf
Goddamn ABBV chill the fuck out so I can sell my covered call at the top
Ran a little AI search last night when I was extremely crossfaded. Drug: Atorvastatin/Lipitor (PFE). US prescriptions: >115 million. Generic market share penetration: >90%. Drug: Lisinopril/Zestril (AZN). US prescriptions: >76 million. Generic market share penetration: 95% Drug: Levothyroxine/Synthroid (ABBV). US prescriptions: >80m. Generic market share penetration: ~60%
Drug: Atorvastatin/Lipitor (stock PFE). US prescriptions: >115 million. Generic market share penetration: >90%. Drug: Lisinopril/Zestril (AZN). US prescriptions: >76 million. Generic market share penetration: 95% Drug: Levothyroxine/Synthroid (ABBV). US prescriptions: >80m. Generic market share penetration: ~60% Read the fucking news. **BIG DICK MONEY INBOUND**
ABBV and CMI have been very good to me (and put money in my pocket)
ABBV crushing it lately
ABBV probably continues up tomorrow
Whoever told me to buy ABBV @ 110 a couple of years ago, thank you.
Why does ABBV go crazy in the premarket? Today especially? It seems like it goes up x% then draws back to a little bit above baseline every day
ALGN is a monopoly all competitors are cooked. It’s the reason I invested heavily into ABBV the moment they bought allergen. People will spend on their teeth. Plus they have a new state of the art scanner orthos will be forced to use. Also they were hit with 30% tariffs from Mexico, which will fade if not they are priced in. Nice catalyst. Easy 2-3x within 5 years it’s a gift. Hit it with size myself. It’s right at my average here. Gift of an entry.
Yeah, sure (sorry, this is a bit of a rambling rant, but gives you a little look inside my controlled chaos). The common theme is really simple, find wonderful companies and just keep buying them at decent value points and holding more and more over long periods of time. Before I started investing I tore through a bunch of books. I started following companies and engaging daily. Researching companies, jumping on earnings calls, looking over financials. I learned the foundational aspects of the art of valuation. The book that struck me the most was One up on Wall Street. We run into incredible companies all over in everyday life, keep your eyes open and you'll see them. That gives you a great spot to start your research. When you find good ones buy, get to know them better and if you're right buy more. Then buy some more and keep buying. And if you're wrong cut bait and move on quickly. IMO, reading and learning is lost on too many coming into investing today. If you don't want to learn and don't enjoy learning about the details of how a business functions you shouldn't be investing in equities. If you enjoy that as a hobby and want to use your time to do those activities, equity investing may be for you. This led me to buy Apple in 2008, Activision in 2009. Netflix and Google in 2011. Costco in 2012. Casey's General Store in 2012. Tesla in 2013 (although I'll still argue this was a stupid move by me as the financials were scary). NVDA in 2017. MELI in 2020. It also led me to others at great value points too like OKE and ABBV and NTDOY and 6016.T and KNSL. All solid, well run companies with a level of pricing power and some special sauce. And I don't really sell, if it's working I look for spots to add more. Also, I slowly built a cash allocation plan. I never invest just b/c I have money. I stack money until I high conviction idea. And I don't just buy once, I generally aim to build a position out over time, getting to know a company better and better and building knowledge and conviction...or not and then I cut bait. That may lead to long periods where I'm sitting on cash equivalents (like SGOV and some select Munis and high quality Bonds right now). But then when I see value I generally go crazy. Example, in 2018/19 I was building a few positions (like NVDA) but largely building cash as I didn't have any great ideas. I was still buying small tranches of my favorite companies, but in small increments (I'll be a net buyer of equities until I die). Then when 2020 hit valuations were massively attractive so I went crazy. I made about 100 buys between Feb and August. Did the same in April of this year...over a 2 week period I deployed a massive pile of cash. When the market provides attractive valuations, I always have cash ready to go. I'll never deploy 100% of my cash and new money always goes immediately to cash holdings. Options -- My thoughts are simple...if valuations are stretched and you're ok moving on from some shares, sell covered calls. If valuations are low and you would like to take on some shares at specific price points, sell puts. Around 2013 I picked up Options as a Strategic Investment (the options bible IMO). I don't necessarily aim to TRADE, but to use options as part of my long term buy and hold strategy. That leads to me SELLING a ton of options, but buying very very few. In April of this year I sold a ton of puts at prices I wanted to add shares. I'm generally very conservative here so the only equity I took on was HIMS in the 25-30 range (below my fair value range by a fair %). The others just added cash to the cash pile. Google is a good example. I was selling puts in the 120-135 range, but I was also buying a little in the 150-170 range. Recently I've been selling a lot of HIMS (overvalued from my 33-37 fair value range), NVDA (I never rebalance to rebalance but this position is extreme and above my 130-142 fair value range) and AAPL (above my 180ish fair value range) covered calls. I've also been selling CRM puts in a conservative 205-220 range (just above my 197 bear case and below my 225-250 fair value range). I don't recommend options for most, but if you really have a good feel for valuations you can use them strategically to get in and out of positions and drive additional cash to invest.
I have to agree that having SCHG and VOO is pointless after reading my own comment about growth over 5 years. Makes no sense. I'd consider selling SCHG to take more concentrated positions in MSFT, NVDA, UNH, ABBV, and GOOG but if we're talking ASTS, PLTR, and HOOD growth type stocks then I don't have the dry powder for that. I don't even know which companies have that potential right now. Either way, I was looking at the fees, which are on top of commission, and it's not worth it to get a managed fund. Some fund managers absolutely kill it, but they're not hanging around my price point.
60% ABT and 40% ABBV. Growth and sweet dividend hard to beat. Neither company is going anywhere.
That's incredible! We need more days like this! While tech is being decimated... other sectors are attracting all the money! Berkshire, AZN, MRK, ... TJX, DOW, UL, ABBV, ...
I bought 100 shares of GILD and ABBV to write covered calls at the top
I bought 100 shares of GILD and ABBV to write covered calls at the top
Oral data due imminently, fireworks to come, could see plus or minus $25. My bet is plus given the overwhelming positive data released in both SQ and oral. Remember it’s the same compound. Just a matter of time before PFE, MRK or ABBV takes them out imo.
Doesn’t $ABBV grow more than anyone else?
Somehow lost 30k on AMD calls before big run up. But really hit with Boeing, ABBV and recently Apple. So need to push out some gains until next year while still participating.
3% diagnosed. probably more like 7-10% with undiagnosed, and only about 50% of diagnosed people are still untreated. even just 15 million people is a huge patient population. also ABBV has an insane amount of money to burn on ads and losing Humira means they're pumping all the old budget at the replacements including rizi
RSG, ABBV, WMT Fund-wise BRW (Saba Capital Income & Opportunities Fund) is an interesting CEF that has done pretty well since Saba Capital took it over and changed the fund entirely in 2021. It lost 4% in 2022 when the market was tanking and lost comparatively less than the market when the market was tanking in 2025, yet has also done pretty well when the market has.
Oh so now that ABBV had great earnings the market wants to tank. Fucks sake
Even my ABBV will hit 200 before my GOOGL…
Imagine buying any other healthcare other than ABBV
ABBV is my only healthcare only left, dont let me down you fucks..
I own UNH, PFE, and ABBV so it probably makes up a good chunk of my taxable account. I'm not that worried about it though unless the U.S. moved to a Universal Healthcare System. In which case, I would gladly take the loss.
If this amount of yours in a tax-privileged account (IRA, 401k), you can move the funds in a 3-tier layout: 33% bonds, 34% divident-paying safe stocks (ABBV, etc) and 33% in etfs (VOO, SCHD, VTI).
The fact that $VKTX can offer potential oral and monthly maintenance after SC with the same molecule is not to be underestimated. Even $LLy does not have that. It is uncertain how people will react when switching from TP to orfoglipron.. large pharma eyes on that as almost everyone there is talking about need for solutions for long-term adherence beyond 1-2 years. Listen to $ABBV $PFE and others. Don’t believe $NVO semaglutide is competitive with that Viking only needs to show that small dose oral has any activity in phase 2 in a few weeks
SIGH i have been saying since premarket…why choose to turn a deaf ear? good news is we will stop the dump soon FOR TODAY, ur only chance to cut losses. we will continue to dump over the few weeks. in the meantime the index will go up a little as we readjust portfolio if u prefer to hold stocks buy NKE PG CPB KHC CAG JNJ MRK XHB ABBV BRKB UNH
Someone hold me. ABBV betrayed me e
you're actually right. the foreskin moisturizer from AGN now ABBV is amazing and $295
ABBV random red candle just completely undid all this morning progress
Buy - ACHR NIO PFE UNH Sell - ABBV CCL CRCL
You're talking about defensive and for health you're listing four biotechs - while I do like a couple of those they are absolutely not "defensive." Some of healthcare is defensive (ABBV/ABT, for example) but definitely not all of it.
Good to see another mention of ABBV
ABBV Excellent growth and dividends.
so if i go to CVS im getting stuff made by ABBV. IF I go to HIMS i am getting stuff that HIMS made due to a shortage.
ABBV is such a buy right now, it has no reason being this low
Looking for opinions on ABBV—saw a stair-step pattern and took a $10K position Noticed ABBV has been climbing in a stair-step pattern—slow grind up, then tight sideways moves. Looks like classic institutional accumulation. Vanguard and BlackRock have increased their positions recently, while some banks are selling off. Between the \~3.6% dividend and their recent M&A push into oncology and neuroscience, I saw a decent entry point and put $10K in. Curious what others think—am I seeing strength or stepping into a value trap?
FICO, COST, CEG, PGR, ABBV, HII, just some ideas.
Brokerage is up 30% in large part cause palantir, avgo, Netflix, ABBV has helped. What has not helped is I bought Reddit and SMCI at prices higher than I should have
Join my tictok @Devinbaily99 I post sna I shots of my leading stocks and share what's working for me. Some of my biggest % gains over past few years has been META NVDA ABBV CLH CAT <________________ I also recommend an index and let it run till retirement fir the compounded interest. -Devin
best part is that doesnt matter if this works or not, it will get bought out by ABBV and the OP will be a millionare
PUTS on NKE, SBUX, INTC, and ABBV. Otherwise pickings be slim at this point since UNH ran it’s course
Someone please save ABBV 
they were down, very early morning (maybe futures only I’m not sure yet what I saw) but VRTX, ABBV, LLY and JNJ were definitely down, and I think many more. I was eager to buy calls on them because this EO will not execute, and once people realized that, the stocks will just go up again. But I was also researching some other stock. I looked at the stocks in the afternoon, and they were already up again. So I just left kt
Lol $ABBV 
Whichever one dips the most PFE, JNJ, MRK, ABBV, BMY, AMGN, GILD, NVS, SNY
My ABBV calls are cooked if what this retard says actually moved pharma
Nice, that's a cool idea. I'm probably buying CATL at its introduction on the HK exchange. A couple of other funny non US bets of mine you could follow, for the fun of it. ABB (ABB.ST), ATCO (ACO-X.TO), Kaspi.kz (KSPI Nasdaq), Reliance Industries (RIDGL.XC) and Tryg a/s (TRYG.CO) Set a reminder for a few years and come rub my face in it, when the US had kept out performing the rest of the world yet again. To make it worse, I sold ABBV, SO, CSCO, LMT, NOC, GLW and TXN in January, to cut my US exposure in half. Dumped most in my mortgage and the rest went into ABB, RIO and Reliance. At this point it seems nearly prescient, given how the USD has crashed, though I assure you it is pure luck.
So... Trump going to cause death and suffering. Just like last time. Fyi, I still have no idea how Eli lilly is going to find the money for its announcement of $50 billion in US manufacturing. https://finance.yahoo.com/quote/LLY/balance-sheet/ It's definitely not coming from inside the company with a balance sheet like that and are they really going to take billions of corporate bonds out in the tune of potentially 6-7% as US Treasury yields spike? They're already paying 5.74%. ABBV is paying 6.0%.
Hey guys! Trading Recap (4/29/25) 💯 12 for 16 = 75% ✅ Hits: $WW (x4), $ABVE, $NVNI, $ABAT, $OMH, $WOLF, $PLUG, $PE, ABBV (options call)
I’m recommending the ABBV 180 calls for May 16 if you wanna chase here
Fuck yeah homie. I sold all my calls at close today. Not holding through earnings. I did see a lot of call buying in out of the money calls expiring tomorrow that we're buy to open because the volume was higher than the open interest. Looking at the after hours trading in ABBV It was a mistake to sell those calls but you just never know and I've gotten destroyed by holding options through earnings. Hopefully ABBV rips up 20% tomorrow haha.
!banbet ABBV 170 16h
I believe it’s ABBV that owns Durata via them buying Allwergan
I listened to some regard on the earnings page and bought ABBV puts before close. Lets see how fucked I am.
+140% ABBV calls aaaaand I’m holding til tomorrow
https://preview.redd.it/2nf7na621uwe1.jpeg?width=1440&format=pjpg&auto=webp&s=aee9f90fa5010a6ca3ed3c645f5a912e04aa9f1c ABBV calls expiring tomorrow executed at the ask. Volume greater than open interest 👀. Earnings tomorrow at 730AM
Anyone playing ABBV? Health stocks haven't been doing so hot recently so I'm thinking puts
Whats a good Google 1dte option to play? And maybe ABBV?
https://preview.redd.it/1ouvhivawrwe1.jpeg?width=1440&format=pjpg&auto=webp&s=a036ad69622276d0b3ebcf93ba31ac66c196876e 11 $180.00 calls and two $190.00 calls. I am selling before close however because I hate holding through earnings and having a winner turn into a loser. Full disclosure. I think $ABBV will close above $179.00 today.
https://preview.redd.it/w63toxqivrwe1.jpeg?width=1440&format=pjpg&auto=webp&s=d2ae5623e112fa94f86ebdeb209c8cce914470c5 11 $180.00 calls and two $190.00 calls. I am selling before close however because I hate holding through earnings and having a winner turn into a loser. Full disclosure. I think $ABBV will close above $179.00 today.
If what prints? The earnings, $ABBV stock, $ABBV calls?
$ABBV has a large US manufacturing presence that will mitigate most of the tariffs. The majority of their manufacturing is done domestically.
Buy $ABBV stock and $ABBV 4/25/2025 calls today. $ABBV reports earnings tomorrow @ 07:35 AM. ABBV has a P/E ratio of 14.5 and prints cash. Revenue from drugs Skyrizi and Rinvoq are projected to exceed $30 billion by 2027.
Buy ABBV 4/25 CALLS BEFORE CLOSE FOR EARNINGS RELEASE FRIDAY
I am closing my $ABBV calls at close most likely and depending on where we're at EOD, buying SPX Puts 1DTE
https://preview.redd.it/ft1ljnq8lfwe1.png?width=1440&format=png&auto=webp&s=a495ab445536af5d2b1df903a820b4299628bbf6 POSITIONS: 11 ABBV $180.00 4/25 CALLS 2 ABBV $190.00 4/25 CALLS
What was your reason for buying ABBV calls? I have 09/19 $200. I see it’s bounced off a 7 year trend line.